Cardiovascular pathophysiology of ovarian hormones;Physiopathologie cardio-vasculaire des hormones ovariennes

Praxis

Volumn 86, Issue 5, 1997, Pages 138-144

  De Ziegler, D ^a  

^a Groupement Hospitalier de l'Ouest Lemanique   (Switzerland)

Author keywords

cardiovascular; estradiol; hormone replacement therapy (HRT); progesterone

Indexed keywords

ESTRADIOL; ESTROGEN; PROGESTERONE;

ARTICLE; FEMALE; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; ISCHEMIC HEART DISEASE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; CHILD; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; LIPIDS; MACACA FASCICULARIS; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; RISK FACTORS; VASCULAR RESISTANCE; VASODILATION;

EID: 0031045075     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Kannel W. B., Hjortland M. C., McNamara P. M., Gordon T.: Menopause and risk of cardiovascular disease: The Framingham Study. Ann Intern Med 1976; 85: 447-52.
2. Golditz G. A., Wiltet W. C., Stamper M. J., Rosner B., Speizer F. E., Hennekens C. H.: Menopause and the risk of coronary heart disease in women. N Engl J Med 1987; 326: 1105-10.
3. Wuest J. H. Jr., Dry T. J., Edwards J. E.:The degree of coronary atherosclerosis in bilaterally ophorectomized women. Circulation 1953; 7: 801-9.
4. Ross R. K., Paganini-Hill A., Mack T. M., Arthur M., Henderson B. E.: Menopausal estrogen therapy and protection from death from ischaemic heart disease. Lancet 1981:1: 858-60.
5. Lobo R. A. Clinical review 27: effects of hormonal replacement on lipids and lipoproteins in postmenopausal women. J. Clin Endocrinol Metab 1991; 73: 929-30.
6. Bergqvist A., Bergqvist D., Ferno M.: Estrogen and progesterone receptors in vessel vails. Biochemical and immunochemical assays. Acta Obstet Gynecol Scand 72. 1993; 72: 10-16.
7. Bourne T., Hillard T. C. Whitehead M. I., Crook D., Campbell S.: Estrogens, arterial status, and postmenopausal women. The Lancet 1990; 335: 1471-2.
8. de Ziegler D., Bessis R., Frydman R.: Résistance vasculaire des artères utérines évaluées par Doppler puisé transvaginal et effets hormonaux. Reproduction Humain et Hormone 1991; 4: 69-31.
9. Hillard T. C., Bourne T. H., Whitehead M. I., Crayford T. B., Collins W. P., Campbell S.: Differential effects of transdermal estradiol and sequential progestogens on impedence to flow within the uterine arteries of postmenopausal women. Fertil Steril 1992; 58: 959-63.
10. Gangar K. F., Vyas S., Whithead M., Crook D., Meire H., Campbell S.: Pulsalility index in internal carotid artery in relation to transdermal estradiol and time since menopause. Lancet 1991; 338: 839-42.
11. Rosano G. M. C, Sarrel P. M., Chierchia S. L., Morgagni G. L., Gabriele M., Leonardo F., Sontag G., Beale C., Collins P.: Medroxyprogesterone hut not natural progesterone reverses the effect of estradiol 17-ß upon exercise induced myocardial ischemia. A double-blind cross-over-study. Will be presented at Sydney. Nov. 1996.
12. Clarkson T. B., Anthony M. S., Potvin Klein K.: Effets of estrogen treatment on arterial wall structure and function. Drugs 47 (suppl. 2) 1994.
13. Reis S. E., Gloth S. T., Blumenthal R. S., Resar J. R., Zacur H. A., Gerstenblith G., Brinker J. A.: Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation 1994; 89: 52-60.
14. Gilligan D. M., Quyyumi A. A., Cannon R. O.: Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 1994; 89: 2545-2551.
15. Collins P., Rosano G. M., Sarrel P. M., Ulrich L., Adamopoulos S., Beale C. M.: 17ß-estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation 1995; 92: 24-30.
16. Kaplan J. R., Adams M. R., Clarkson T. B., Koritnik D. R.: Psychosocial influences on female «protection» among cynomolgus macaques. Atherosclerosis 1984; 53: 283-295.
17. Adams M. R., Kaplan J. R., Koritnik D. R., Parks J. S. et al.: Pregnancy-associated inhibition of coronary artery atherosclerosis in monkeys. Arteriosclerosis 1987; 7: 378-384.
18. Adams M. R., Kaplan J. R., Clarkson T. B., Koritnik D. R.: Ovariectomy, social status, and atherosclerosis in cynomolgus monkeys. Arteriosclerosis 1985a; 5: 192-200.
19. Adams M. R., Williams J. K., Clarkson T. B., Jayo M. J.: Effects of estrogens and progestogens on coronary atherosclerosis and osteoporosis of monkeys. In: Christiansen (ed.), Baillière's clinical obsterics and gynaecology: international practice and research: hormone replacement and its impact on osteoporosis. Baillière Tindall. London 1991; pp. 915-934.
20. Clarkson T. B., Adams M. R., Williams J. K., Wagner J. D.: Clinical implications of animal models of gender difference in heart disease. In: Douglas P. (ed.). Cardiovascular health and disease in women, chap. 15, pp. 283-302. W. B. Saunders, Philadelphia 1993.
21. Persson J., Formgren J., Israelsson B., Berglimd G.: Ultrasound-determined intima-media thickness and atherosclerosis. Arteriosclerosis and Thrombosis 1994; 14: 261-264.
22. Gemulakos G., O'Gorman D., Nicolaides A., Sheridan D., Elkeles R., Shaper A. G.: Carotid intima-media thickness: correlation with the British Regional Heart Study risk score. J Int Med 1994; 235: 431-433.
23. Blankenhorn D. H.: Atherosclerosis of the aorta and coronary arteries in five towns. Bull World Health Organ 1976; 53: 485-653.
24. Mack W.J., Selzer R. H., Hodis H. N., Erickson J. K., Liu Ch., Liu Ci., Crawford D. W., Blankenhorn D. H.: One-year reduction and longitudinal analysis of carotid intima-media thickness associated with Colestipol/Niacin therapy. Stroke 1993; 24: 1779-1783.
25. Gariepy J., Massonneau M., Levenson J., Heudes D., Simon A. and the Groupe de Prevention Cardio-vasculaire en Médecine du Travail: Evidence for in vivo carotid and femoral wall thickening in human hypertension. Hypertension 1993; 22: 111-118.